Filing Details
- Accession Number:
- 0001438133-20-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-01-17 18:57:35
- Reporting Period:
- 2020-01-16
- Accepted Time:
- 2020-01-17 18:57:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1438133 | Tandem Diabetes Care Inc | TNDM | Surgical & Medical Instruments & Apparatus (3841) | 204327508 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1542377 | B Brian Hansen | 11075 Roselle St San Diego CA 92121 | Evp & Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-01-16 | 10,000 | $0.00 | 12,991 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-01-16 | 10,000 | $69.76 | 2,991 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option | Acquisiton | 2020-01-16 | 10,000 | $0.00 | 10,000 | $2.59 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | M | Direct |
Footnotes
- The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2019.
- The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $69.76 and $69.77.
- The option shall vest as to fifty percent (50%) of the underlying shares on 12/01/2018, and the remaining shares shall vest in twelve (12) equalmonthly installments thereafter.
- The expiration date for these options is 10 years from the date of grant.